BOSTON, MA, August 26, 2026 (EZ Newswire) -- Four Massachusetts retailers of natural kratom leaf products have filed a lawsuit in Suffolk County Superior Court against the state Department of Public Health and its commissioner, Robbie Goldstein, alleging the Commonwealth's new blanket ban on all kratom products does not meet standards established by the Legislature.
The complaint for declaratory and injunctive relief, dated Aug. 21, also faults the defendants for failing to distinguish between natural kratom leaf and chemically manipulated 7-hydroxymitragynine (7-OH), as well as for relying on death data that does not distinguish the traditional leaf from chemically manipulated products.
Natural kratom is derived from the leaves of a Southeast Asian tree and has been consumed for centuries. Today, millions of Americans and tens of thousands of Bay Staters regularly purchase natural kratom leaf products in the commercial retail marketplace. By contrast, concentrated or synthetically isolated 7-OH products represent high-potency formulations distinct from traditional, raw botanical kratom leaf.
Massachusetts' blanket kratom ban will have significant unintended economic consequences, particularly for businesses that operate legally, transparently, and in compliance with state and local laws. The new order risks crushing an entire category of legitimate commerce in natural kratom and will cause major job losses and economic harm.
Regulatory action threatens to eliminate retail inventory and jobs without providing a workable regulatory compliance framework, despite the fact that legal kratom businesses contribute to the economy through sales and payroll taxes, commercial rent, and local fees. Driving these businesses out of the regulated market reduces state and local revenue while pushing demand into unregulated channels.
This is why the Department of Public Health must reverse its order and pursue a targeted, science-based approach that protects young people, establishes appropriate consumer safeguards, and focuses enforcement on chemically manipulated products, not responsible retailers of natural kratom leaf. A narrower approach would align with recent federal actions by the FDA and DEA, which initiated temporary scheduling procedures targeting concentrated 7-OH and synthetic alkaloid derivatives while distinguishing them from raw leaf.
Retailers who have lawfully sold natural kratom leaf for years should not suddenly face criminal consequences because dangerous new products have entered the marketplace.
About American Kratom Association (AKA)
The American Kratom Association is a consumer advocacy organization dedicated to protecting the rights of Americans to safely use natural kratom products. The AKA supports federal and state enforcement actions targeting chemically manipulated 7-OH products and advocates for the Kratom Consumer Protection Act — including product testing, labeling standards, and age restrictions — in states across the country. For more information, visit americankratom.org and learn more at kratomanswers.org.
Disclaimer
The American Kratom Association (AKA) is a 501(c)(4) advocacy organization. This press release is provided for informational and public policy purposes only. Content herein reflects the statements and unverified legal allegations of the issuing party and does not constitute endorsement, legal advice, or medical advice by this publication. Statements made regarding natural kratom have not been evaluated by the Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure, or prevent any disease. Readers should consult qualified medical professionals before using any botanical products.
Media Contact
Mac Haddow
Senior Fellow on Public Policy
press@americankratom.org
+1 571-294-5978
###
SOURCE: American Kratom Association (AKA)
For questions regarding this release or its content, contact hello@eznewswire.com for immediate assistance.